Smolen VF[au] - Search Results

Year	Number of Results
1968	2
1970	4
1971	6
1972	6
1973	2
1974	2
1975	3
1976	6
1977	1
1978	1
1981	1
2022	0

1

Bioavailability and pharmacokinetic analysis of drug responding systems.

Smolen VF. Smolen VF. Annu Rev Pharmacol Toxicol. 1978;18:495-522. doi: 10.1146/annurev.pa.18.040178.002431. Annu Rev Pharmacol Toxicol. 1978. PMID: 348066 Review. No abstract available.

2

Pharmacokinetics of chlorpromazine-induced miotic response in rabbits.

Kuehn PB, Jhawar AK, Weigand WA, Smolen VF. Kuehn PB, et al. Among authors: smolen vf. J Pharm Sci. 1976 Nov;65(11):1593-9. doi: 10.1002/jps.2600651109. J Pharm Sci. 1976. PMID: 1032895

3

Determination of CMC from liquid junction potential measurements.

Williams EJ, Smolen VF. Williams EJ, et al. Among authors: smolen vf. J Pharm Sci. 1972 Apr;61(4):639-41. doi: 10.1002/jps.2600610436. J Pharm Sci. 1972. PMID: 5014328 No abstract available.

4

Procaine interaction with the corneal surface and its relation to anesthesia.

Smolen VF, Siegel FP. Smolen VF, et al. J Pharm Sci. 1968 Mar;57(3):378-84. doi: 10.1002/jps.2600570302. J Pharm Sci. 1968. PMID: 5655574 No abstract available.

5

Bioavailability analysis of chlorpromazine in humans from pupilometric data.

Smolen VF, Murdock HR Jr, Williams EJ. Smolen VF, et al. J Pharmacol Exp Ther. 1975 Dec;195(3):404-15. J Pharmacol Exp Ther. 1975. PMID: 1195127

6

Bioavailability and pharmacokinetic analysis of chlorpromazine-induced rectal temperature depression in rabbits.

Smolen VF, Jhawar AK, Weigand WA, Paolino RM, Kuehn PB. Smolen VF, et al. J Pharm Sci. 1976 Nov;65(11):1600-5. doi: 10.1002/jps.2600651110. J Pharm Sci. 1976. PMID: 993990

7

Biophasic availability of ophthalmic carbachol. I. Mechanisms of cationic polymer- and surfactant-promoted miotic activity.

Smolen VF, Clevenger JM, Williams EJ, Bergdolt MW. Smolen VF, et al. J Pharm Sci. 1973 Jun;62(6):958-61. doi: 10.1002/jps.2600620621. J Pharm Sci. 1973. PMID: 4712631 No abstract available.

8

Pharmacological response data for comparative bioavailability studies of chlorpromazine oral dosage forms in humans: I. Pupilometry.

Smolen VF, Murdock HR Jr, Stoltman WP, Clevenger JW, Combs LW, Williams EJ. Smolen VF, et al. J Clin Pharmacol. 1975 Nov-Dec;15(11-12):734-51. doi: 10.1002/j.1552-4604.1975.tb02338.x. J Clin Pharmacol. 1975. PMID: 1104666 Clinical Trial.

9

Predictive conversion of in vitro drug dissolution data into in vivo drug response versus time profiles exemplified for plasma levels of warfarin.

Smolen VF, Erb RJ. Smolen VF, et al. J Pharm Sci. 1977 Mar;66(3):297-304. doi: 10.1002/jps.2600660302. J Pharm Sci. 1977. PMID: 845793

10

Drug-biomolecule interactions: bioelectrometric study of the mechanism of carbachol interactions with the cornea and its relation to miotic activity.

Smolen VF, Park CS, Williams EJ. Smolen VF, et al. J Pharm Sci. 1975 Mar;64(3):520-8. doi: 10.1002/jps.2600640344. J Pharm Sci. 1975. PMID: 239195

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results